I71.010 Insurance Policy Changes

ICD-10 I71.010 is officially defined as "Dissection of ascending aorta." code I71.010 is referenced in 3 tracked payer policy changes from Aetna and Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code I71.010 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 1, 2026Medium impact
Endovascular Repair of Aortic Diseases (CPB 0651, reviewed 2026-09-25)
Aetna considers endovascular repair of infra-renal abdominal or aorto-iliac aneurysms medically necessary when an FDA-approved fenestrated, branched or non-fenestrated endovascular stent graft is used, and endovascular repair of descending thoracic aneurysms medically necessary when an FDA-approved endoprosthesis is used. The policy also covers endovascular stenting for aortic coarctation in patients with systemic arterial hypertension and a resting arm-leg pressure gradient greater than 20 mmHg, and endovascular treatment of pulmonary artery stenosis or hypoplasia in a child. Bifurcated-bifurcated aneurysm repair, the Nellix endovascular aneurysm sealing system, endovascular repair of non-dissected ascending aortic disease, fabric wrapping, implanted wireless pressure sensors for endoleak detection, the Nectero EAST system, pre-operative inferior mesenteric artery embolization to reduce type II endoleak, and total endovascular aortic arch repair are listed as experimental, investigational or unproven.
Aetna · Identified Aug 14, 2026Medium impact
Endovascular Repair of Aortic Diseases (CPB 0651, reviewed 2026-04-24)
Aetna Clinical Policy Bulletin 0651 covers endovascular repair of aortic diseases. Aetna considers endovascular repair of infra-renal abdominal aortic or aorto-iliac aneurysms with an FDA-approved fenestrated, branched or non-fenestrated stent graft medically necessary, endovascular repair of descending thoracic aortic aneurysms with an FDA-approved endoprosthesis medically necessary, endovascular stenting with an FDA-approved stent for aortic coarctation in persons weighing 1.5 kg (3.3 lbs) or more who have systemic arterial hypertension and a resting arm-leg pressure gradient greater than 20 mmHg medically necessary, and endovascular treatment for pulmonary artery stenosis and/or hypoplasia in a child medically necessary. Bifurcated-bifurcated aneurysm repair, the Nellix endovascular aneurysm sealing system, endovascular repair of non-dissected ascending aortic diseases, fabric wrapping of abdominal aortic aneurysms, implanted wireless pressure sensors for detecting endoleaks, the Nectero EAST system, pre-operative embolization of the inferior mesenteric artery to reduce type II endoleak, and total endovascular aortic arch repair are considered experimental, investigational or unproven.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Endovascular Stent Grafts for Disorders of the Thoracic Aorta
Endovascular stent grafts using FDA-approved devices may be considered medically necessary for descending thoracic aortic aneurysms used according to FDA-approved specifications, for acute complicated (organ or limb ischemia or rupture) type B thoracic aortic dissection, and for traumatic descending aortic tears or rupture. Endovascular stent grafts are investigational for descending aortic disorders that do not meet these criteria, including uncomplicated aortic dissection, and for ascending aortic disorders, including thoracic aortic arch aneurysms. The 05/29/2026 update changed the device description and the policy guidelines on endograft placement and removed the ICD-9 procedure and diagnosis codes from the code reference, with the policy statements unchanged.

Watch I71.010

Get one email when a payer policy names I71.010, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code I71.010?

There are 3 tracked policy changes affecting code I71.010, including updates from Aetna, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code I71.010?

Payers that have issued tracked updates for code I71.010 include: Aetna, Blue Cross & Blue Shield of Mississippi.

How do I get notified when code I71.010 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code I71.010. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code I71.010?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Endovascular Repair of Aortic Diseases (CPB 0651, reviewed 2026-09-25)

Endovascular Repair of Aortic Diseases (CPB 0651, reviewed 2026-04-24)

Endovascular Stent Grafts for Disorders of the Thoracic Aorta

What insurance policy changes affect code I71.010?

Which payers have updated policy for code I71.010?

How do I get notified when code I71.010 policy changes?

Why do payers change policies for code I71.010?